A judge Thursday denied a request by notorious “Pharma Bro” Martin Shkreli to postpone paying nearly $25 million he owes as part of a judgment in a civil case for engaging in anticompetitive conduct to protect his drug company’s profits.
The ruling comes two months after the same Manhattan federal judge banned Shkreli, 39, for life from the pharmaceuticals industry and ordered him to pay a total of $64.6 million he earned from hiking the price of the lifesaving drug Daraprim by more than 4,000% overnight.
Shkreli’s illegal conduct delayed the entry of a competitor to the anti-parasitic medication for at least 18 months after the price boost, the judge said.
